HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne Goodeve Selected Research

Type 1 von Willebrand Disease

5/2013Principles of care for the diagnosis and treatment of von Willebrand disease.
3/2013VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
11/2010The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
5/2008Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
4/2008Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
9/2007Genetics of type 1 von Willebrand disease.
4/2007Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
1/2007Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne Goodeve Research Topics

Disease

9Hemorrhage
03/2023 - 01/2007
8Type 1 von Willebrand Disease
05/2013 - 01/2007
6Hemophilia A (Haemophilia)
05/2013 - 06/2003
4von Willebrand Diseases (von Willebrand's Disease)
03/2023 - 05/2013
3Type 3 von Willebrand Disease
10/2021 - 07/2011
1Hemarthrosis
01/2020
1Epistaxis (Nosebleed)
01/2020
1Menorrhagia
01/2020
1Thrombotic Thrombocytopenic Purpura
10/2018
1Afibrinogenemia (Fibrinogen Deficiency)
01/2017
1deficiency Von willebrand factor
05/2013
1Hemophilia B (Haemophilia B)
01/2013

Drug/Important Bio-Agent (IBA)

10von Willebrand FactorIBA
01/2022 - 01/2007
7Factor VIII (Coagulation Factor VIII)IBA
01/2020 - 06/2003
5Biomarkers (Surrogate Marker)IBA
03/2013 - 01/2007
4Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
10/2018 - 04/2008
3Proteins (Proteins, Gene)FDA Link
03/2023 - 05/2013
2Blood Coagulation Factors (Coagulation Factor)IBA
09/2011 - 06/2003
2DNA (Deoxyribonucleic Acid)IBA
11/2004 - 06/2003
1AntigensIBA
01/2020
1Hemostatics (Antihemorrhagics)IBA
01/2020
1Fibrinogen (Factor I)FDA Link
01/2017
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2013
1Blood Group Antigens (Blood Groups)IBA
09/2007
1human F8 proteinFDA Link
06/2003

Therapy/Procedure

1Tooth Extraction (Tooth Extractions)
01/2020